<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font21 { font-size : 21; } .font22 { font-size : 22; } .font10 { font-size : 10; } .font27 { font-size : 27; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">and </span>
   <span class="font27">the </span>
   <span class="font22">al., </span>
   <span class="font21">with </span>
   <span class="font17">(). </span>
   <span class="font16">SFTSV </span>
   <span class="font16">was </span>
   <span class="font16">virus </span>
   <span class="font15">that </span>
   <span class="font14">for </span>
   <span class="font14">fever </span>
   <span class="font14">ribavirin </span>
   <span class="font14">The </span>
   <span class="font14">al.. </span>
   <span class="font13">SFTS </span>
   <span class="font13">against </span>
   <span class="font13">thrombocytopenia </span>
   <span class="font13">patients </span>
   <span class="font13">severe </span>
   <span class="font13">Day </span>
   <span class="font13">syndrome </span>
   <span class="font12">antiviral </span>
   <span class="font12">{background </span>
   <span class="font12">infection </span>
   <span class="font12">mg/kg/day </span>
   <span class="font12">strain </span>
   <span class="font12">treatment </span>
   <span class="font12">viral </span>
   <span class="font12">favipiravir </span>
   <span class="font12">are </span>
   <span class="font12">efficacy </span>
   <span class="font12">vitro </span>
   <span class="font12">from </span>
   <span class="font12">margin </span>
   <span class="font11">drugs </span>
   <span class="font11">mice </span>
   <span class="font11">{border-style </span>
   <span class="font11">effective </span>
   <span class="font11">px;} </span>
   <span class="font11">vivo </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">used </span>
   <span class="font11">Antiviral </span>
   <span class="font11">Infect. </span>
   <span class="font11">been </span>
   <span class="font11">Chinese </span>
   <span class="font11">Yield </span>
   <span class="font11">fatality </span>
   <span class="font11">have </span>
   <span class="font11">replication </span>
   <span class="font11">than </span>
   <span class="font11">cells </span>
   <span class="font11">has </span>
   <span class="font11">rate </span>
   <span class="font11">study </span>
   <span class="font11">were </span>
   <span class="font11">(once) </span>
   <span class="font11">Dis., </span>
   <span class="font11">Res., </span>
   <span class="font11">Vero </span>
   <span class="font11">al. </span>
   <span class="font11">also </span>
   <span class="font11">drug </span>
   <span class="font11">not </span>
   <span class="font11">(Table </span>
   <span class="font11">IFN-γ </span>
   <span class="font11">Japanese </span>
   <span class="font11">case </span>
   <span class="font11">effect </span>
   <span class="font11">inhibitory </span>
   <span class="font11">studies </span>
   <span class="font11">virus, </span>
   <span class="font11">who </span>
   <span class="font11">./j.antiviral... </span>
   <span class="font11">activity </span>
   <span class="font11">clinical </span>
   <span class="font11">disease </span>
   <span class="font11">effects </span>
   <span class="font11">mouse </span>
   <span class="font11">nifedipine </span>
   <span class="font11">virus. </span>
   <span class="font11">which </span>
   <span class="font10">&amp;gt; </span>
   <span class="font10">(Tani </span>
   <span class="font10">animal </span>
   <span class="font10">its </span>
   <span class="font10">reduction </span>
   <span class="font10">showed </span>
   <span class="font10">treating </span>
   <span class="font10">when </span>
   <span class="font10">′-FdC </span>
   <span class="font10">(HB) </span>
   <span class="font10">(twice) </span>
   <span class="font10">acid </span>
   <span class="font10">days </span>
   <span class="font10">including </span>
   <span class="font10">models </span>
   <span class="font10">other </span>
   <span class="font10">reduced </span>
   <span class="font10">those </span>
   <span class="font10">treated </span>
   <span class="font10">vitro. </span>
   <span class="font10">RNA </span>
   <span class="font10">SFTS. </span>
   <span class="font10">Tani </span>
   <span class="font10">Virol., </span>
   <span class="font10">amodiaquine </span>
   <span class="font10">did </span>
   <span class="font10">found </span>
   <span class="font10">i.p. </span>
   <span class="font10">lethal </span>
   <span class="font10">px; </span>
   <span class="font10">reported </span>
   <span class="font10">therapy </span>
   <span class="font10">this </span>
   <span class="font10">using </span>
   <span class="font10">{font-family </span>
   <span class="font10">&amp;gt;, </span>
   <span class="font10">(SPL) </span>
   <span class="font10">Because </span>
   <span class="font10">Dr. </span>
   <span class="font10">Favipiravir </span>
   <span class="font10">Health </span>
   <span class="font10">However, </span>
   <span class="font10">Japan </span>
   <span class="font10">Severe </span>
   <span class="font10">TCID </span>
   <span class="font10">after </span>
   <span class="font10">anti-SFTSV </span>
   <span class="font10">can </span>
   <span class="font10">combination </span>
   <span class="font10">font-size </span>
   <span class="font10">hemorrhagic </span>
   <span class="font10">infected </span>
   <span class="font10">infection. </span>
   <span class="font10">influenza </span>
   <span class="font10">inhibitor </span>
   <span class="font10">inhibits </span>
   <span class="font10">novel </span>
   <span class="font10">p.o. </span>
   <span class="font10">post </span>
   <span class="font10">reduction** </span>
   <span class="font10">s.c. </span>
   <span class="font10">should </span>
   <span class="font10">such </span>
   <span class="font10">these </span>
   <span class="font10">various </span>
   <span class="font10">would </span>
   <span class="font10">Baba </span>
   <span class="font10">Chemother., </span>
   <span class="font10">FDA-approved </span>
   <span class="font10">Furthermore, </span>
   <span class="font10">Gowen </span>
   <span class="font10">Ribavirin </span>
   <span class="font10">Sci. </span>
   <span class="font10">Smee </span>
   <span class="font10">This </span>
   <span class="font10">administration </span>
   <span class="font10">between </span>
   <span class="font10">caffeic </span>
   <span class="font10">caused </span>
   <span class="font10">channel </span>
   <span class="font10">conducted </span>
   <span class="font10">considered </span>
   <span class="font10">could </span>
   <span class="font10">development </span>
   <span class="font10">double; </span>
   <span class="font10">hexachlorophene </span>
   <span class="font10">only </span>
   <span class="font10">potential </span>
   <span class="font10">significantly </span>
   <span class="font10">suggested </span>
   <span class="font10">therapeutic </span>
   <span class="font10">viruses </span>
   <span class="font10">(.%) </span>
   <span class="font10">(Li </span>
   <span class="font10">./JVI.- </span>
   <span class="font10">China </span>
   <span class="font10">China, </span>
   <span class="font10">China. </span>
   <span class="font10">Clin. </span>
   <span class="font10">Ebola </span>
   <span class="font10">Med., </span>
   <span class="font10">Shimojima </span>
   <span class="font10">South </span>
   <span class="font10">acid, </span>
   <span class="font10">administrated </span>
   <span class="font10">agents </span>
   <span class="font10">all </span>
   <span class="font10">because </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">but </span>
   <span class="font10">calcium </span>
   <span class="font10">cell </span>
   <span class="font10">cells. </span>
   <span class="font10">compounds </span>
   <span class="font10">dose </span>
   <span class="font10">during </span>
   <span class="font10">identified </span>
   <span class="font10">infection, </span>
   <span class="font10">infections. </span>
   <span class="font10">inhibited </span>
   <span class="font10">inhibitors </span>
   <span class="font10">lower </span>
   <span class="font10">model. </span>
   <span class="font10">received </span>
   <span class="font10">results </span>
   <span class="font10">solid; </span>
   <span class="font10">specific </span>
   <span class="font10">syndrome. </span>
   <span class="font10">tick-borne </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">μM) </span>
   <span class="font10">(Shimojima </span>
   <span class="font10">./s--- </span>
   <span class="font10">Although </span>
   <span class="font10">Amodiaquine </span>
   <span class="font10">CCBs </span>
   <span class="font10">Caffeic </span>
   <span class="font10">Emerg. </span>
   <span class="font10">Huh </span>
   <span class="font10">Korea, </span>
   <span class="font10">Korean </span>
   <span class="font10">Ministry </span>
   <span class="font10">PFU </span>
   <span class="font10">PLoS </span>
   <span class="font10">References </span>
   <span class="font10">SFTSV. </span>
   <span class="font10">UOS </span>
   <span class="font10">Vero, </span>
   <span class="font10">antibodies </span>
   <span class="font10">article </span>
   <span class="font10">bold </span>
   <span class="font10">both </span>
   <span class="font10">broad-spectrum </span>
   <span class="font10">bunyavirus </span>
   <span class="font10">cells, </span>
   <span class="font10">chlorogenic </span>
   <span class="font10">considerable </span>
   <span class="font10">courier; </span>
   <span class="font10">em; </span>
   <span class="font10">entry </span>
   <span class="font10">exchange </span>
   <span class="font10">e–e. </span>
   <span class="font10">first </span>
   <span class="font10">fkj, </span>
   <span class="font10">further </span>
   <span class="font10">group </span>
   <span class="font10">higher </span>
   <span class="font10">host </span>
   <span class="font10">human </span>
   <span class="font10">indicated </span>
   <span class="font10">indicating </span>
   <span class="font10">initiated </span>
   <span class="font10">inoculation, </span>
   <span class="font10">library </span>
   <span class="font10">limited </span>
   <span class="font10">mechanism </span>
   <span class="font10">mechanisms </span>
   <span class="font10">model </span>
   <span class="font10">number </span>
   <span class="font10">observed </span>
   <span class="font10">one </span>
   <span class="font10">platelet </span>
   <span class="font10">protected </span>
   <span class="font10">pt;} </span>
   <span class="font10">related </span>
   <span class="font10">research </span>
   <span class="font10">retrospective </span>
   <span class="font10">shown </span>
   <span class="font10">similar </span>
   <span class="font10">treat </span>
   <span class="font10">treatment. </span>
   <span class="font10">treatments </span>
   <span class="font10">two </span>
   <span class="font10">vaccines </span>
   <span class="font10">weight </span>
   <span class="font10">widely </span>
   <span class="font10">μM, </span>
   <span class="font10">μg/animal </span>
  </p>
 </body>
</html>
